5 Cheap Growth Stocks to Buy According to Billionaire Steve Cohen

Page 5 of 5

1. Affimed N.V. (NASDAQ:AFMD)

Share Price as of December 13: $5.60

Number of Hedge Fund Holders: 19

Affimed N.V. (NASDAQ:AFMD), a biotech company developing cancer immunotherapies, is among the most affordable growth stocks in Steve Cohen’s portfolio. As of the end of the September quarter, Cohen owned 6.12 million shares of the company worth nearly $38 million. Point72 Asset Management is the biggest shareholder of Affimed N.V. (NASDAQ:AFMD) and it accounts for 0.16% of the fund’s total holdings in the third quarter. 

On November 17, Berenberg analyst Zhiqiang Shu initiated a Buy rating on Affimed N.V. (NASDAQ:AFMD) with a price target of $11.

Affimed N.V. (NASDAQ:AFMD) shares surged 22% on November 20 after receiving optimistic early-stage trial data for its lead product candidate, AFM13. The biotech company topped analysts’ estimates by $1.34 million in the third quarter and reported total revenue of $9.94 million.

At the end of the September quarter, 19 hedge funds in the database of Insider Monkey were bullish on Affimed N.V. (NASDAQ:AFMD). The total worth of this stake is $156 million.

You can also take a peek at 10 Best Stocks to Buy for the Next 10 Years and 10 Dividend Aristocrats to Buy for 2022.

Page 5 of 5